Haptoglobin protein and mRNA expression in psoriasis and its clinical significance

  • Authors:
    • Fu-Jun Tian
    • Ying-Ying Zhang
    • Li-Qian Liu
    • Ying Xiong
    • Zong-Shan Wang
    • Shou-Zhong Wang
  • View Affiliations

  • Published online on: August 25, 2016     https://doi.org/10.3892/mmr.2016.5672
  • Pages: 3735-3742
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The present study aimed to explore the association between haptoglobin protein and mRNA expression and psoriasis. A total of 138 patients with psoriasis that were undergoing therapy at Linyi People's Hospital (Linyi, China) between January 2011 and January 2015 were enrolled in the present study. The mRNA expression levels of haptoglobin were detected by in situ hybridization; immunohistochemistry was used to detect haptoglobin protein expression; and double‑labeling immunofluorescence was used to count Langerhans cells; western blotting was also conducted to determine protein expression. A receiver operating characteristic (ROC) curve was generated to assess the diagnostic value of haptoglobin for psoriasis. Compared with the normal and negative control (NC) groups, the mRNA expression levels of haptoglobin were markedly increased in the experimental group (P<0.05). Haptoglobin protein expression was also markedly increased in the experimental group compared with in the normal and NC groups (P<0.05). Conversely, there was no significant difference in haptoglobin expression between the NC group and the normal group (P>0.05). The critical value of haptoglobin mRNA in the diagnosis of psoriasis was 2.93, and sensitivity and specificity were 91.3 and 73.6%, respectively. The area under the ROC curve was 0.883 [95% confidence interval (CI)=0.837‑0.929]. The critical value of haptoglobin protein in the diagnosis of psoriasis was 0.995, and sensitivity and specificity were 76.1 and 99.9%, respectively. The area under the ROC curve was 0.926 (95% CI=0.837‑0.929). The present study demonstrated that the mRNA and protein expression levels of haptoglobin were increased in patients with psoriasis. Haptoglobin mRNA and protein expression were closely associated with the occurrence of psoriasis; therefore, haptoglobin may be considered a promising novel clinical indicator for the diagnosis of psoriasis.

Related Articles

Journal Cover

October-2016
Volume 14 Issue 4

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Tian F, Zhang Y, Liu L, Xiong Y, Wang Z and Wang S: Haptoglobin protein and mRNA expression in psoriasis and its clinical significance. Mol Med Rep 14: 3735-3742, 2016
APA
Tian, F., Zhang, Y., Liu, L., Xiong, Y., Wang, Z., & Wang, S. (2016). Haptoglobin protein and mRNA expression in psoriasis and its clinical significance. Molecular Medicine Reports, 14, 3735-3742. https://doi.org/10.3892/mmr.2016.5672
MLA
Tian, F., Zhang, Y., Liu, L., Xiong, Y., Wang, Z., Wang, S."Haptoglobin protein and mRNA expression in psoriasis and its clinical significance". Molecular Medicine Reports 14.4 (2016): 3735-3742.
Chicago
Tian, F., Zhang, Y., Liu, L., Xiong, Y., Wang, Z., Wang, S."Haptoglobin protein and mRNA expression in psoriasis and its clinical significance". Molecular Medicine Reports 14, no. 4 (2016): 3735-3742. https://doi.org/10.3892/mmr.2016.5672